Acoustic Neuroma (Vestibular Schwannoma): Symptoms, Treatment & When to Seek Care

Symptoms track cranial-nerve VIII dysfunction first, then neighbouring V, VII, and brainstem structures as the lesion grows into the CPA. Many patients are diagnosed after years of gradual hearing change or when MRI is obtained for unrelated reasons.

Early / typical features

• Insidious or stepwise unilateral sensorineural hearing loss with poor speech discrimination relative to tone thresholds.
• Persistent pulsatile or non-pulsatile tinnitus localized to the ipsilateral ear.
• Subtle imbalance, head-motion intolerance, or episodic vertigo—often mistaken for peripheral vestibulopathy.

Larger tumours

• Facial hypoesthesia or trigeminal sensory symptoms if the cisternal segment compresses CN V.
• Facial paresis, lagophthalmos, or dry eye when CN VII is stretched (overlap with urgent Bell palsy mimics—see red-flag box above).
• Pressure headache, nausea/vomiting, or declining consciousness if CSF pathways obstruct.
• Hoarseness, aspiration risk, or tongue weakness when lower cranial nerves are involved—rare until advanced.

Vestibular schwannomas arise when NF2/merlin tumour-suppressor signalling fails in vestibular nerve Schwann cells, allowing monoclonal expansion. Sporadic unilateral disease is far more common than familial NF2.

Modifiable vs non-modifiable (practice framing)

• Non-modifiable: age (middle adulthood peak), sex distribution per epidemiological cohorts, germline NF2 mutation (50% inherited, 50% de novo in many series).
• “Possible modifier” noise exposure appears in population studies; counsel on hearing protection for occupational relevance without implying certainty of cause.
• Incidental MRI detection increases apparent prevalence—document whether symptoms preceded discovery.

Clinical assessment

Map laterality, tempo, occupational impact, speech-in-noise difficulty, imbalance triggers, facial sensation, and eye closure. Formal cognitive batteries are rarely needed; focus on witness account of imbalance falls.

Auditory & vestibular tests

• Pure-tone audiometry with speech discrimination scoring—asymmetric high-frequency loss with disproportionate word recognition drop suggests retrocochlear involvement.
• Acoustic reflex decay, wideband tympanometry adjuncts, or ABR lengthening may support referral urgency when MRI access is queued—never a rule-out tool.
• Video head-impulse or caloric testing sometimes clarifies vestibular hypofunction but does not replace MRI when suspicion persists.

Imaging

Contrast-enhanced MRI with fine-cut IAC protocol is the diagnostic standard: identify intracanalicular vs CPA extension, cystic change, brainstem contact, and hydrocephalus downstream. CT may detail bone for surgical planning but is insufficient alone for soft-tissue diagnosis.

Criteria in practice

Diagnosis is radiological-histopathological rather than scoring-system based. Histology, when obtained, shows classic Antoni A/B schwannoma architecture; pre-operatively the integrative label is imaging plus clinical syndrome.

• Unilateral SNHL + retrocochlear audiology: arrange MRI IAC; synchronize audiology report with referrer to avoid duplicate tests.
• Small tumour, minimal symptoms, non-enlarging on serial imaging: observation with strict MRI calendar, symptom diary, and balance safety netting.
• Progressive growth or disabling cranial-nerve deficit: MDT discussion—microsurgical goals (decompression vs total resection) vs stereotactic radiosurgery for growth control.
• Only-hearing ear or bilateral tumour (NF2): emphasise hearing preservation strategies, rehabilitation, and genetics—routine pathways differ from sporadic cases.
• Acute neurological decline: bypass outpatient queues—ED neuroimaging and neurosurgical notification.

Unilateral auditory-vestibular complaints are common; the bedside task is to avoid anchoring on benign inner-ear disease when red flags accumulate.

↔On a small screen, swipe or scroll sideways to see the full table.

First-line themes (individualised)

• Observation: serial MRI (commonly yearly initially, then extended if stable—per tumour board letter), counsel on driving, heights, and aquatic exercise while imbalance persists.
• Microsurgery: routes (translabyrinthine, retrosigmoid, middle fossa) trade hearing preservation vs exposure—nursing handoffs must state approach and cranial-nerve baselines.
• Stereotactic radiosurgery / radiotherapy: growth control focus; delayed cranial neuropathy or hydrocephalus still possible—surveillance years long.

Adjuncts

• Peri-tumour oedema bridges sometimes use corticosteroids—align glucose checks and GI prophylaxis with prescription.
• NF2-centred systemic options (e.g., bevacizumab in specialist protocols) sit outside routine sporadic tumour pathways.

Special populations

• Older/frail: radiosurgery or observation often favoured—document falls and frailty scores pre-decision.
• Pregnancy: imaging without gadolinium vs risk discussions belong to radiology/obstetrics—defer contrast timing to specialists.
• Profound only-hearing ear: aggressive hearing preservation and rehab coordination—BAHA/CI candidacy per regional programme.

Use tumour-board documentation as the single source for surveillance intervals. Recheck every 6–12 months typically applies to active observation; immediate review follows new brainstem signs, CSF leak, or sudden facial weakness.

• Track growth mm/year on MRI summaries, not patient guesswork.
• Medication reconciliation around anaesthesia, anti-emetics, and corticosteroid tapers—flag QT-prolonging antiemetics if prescribed.
• Treatment failure = documented enlargement on serial imaging, disabling cranial neuropathy progression, or unacceptable quality-of-life symptoms despite conservative care—triggers MDT re-evaluation.
• Referral thresholds: pronounced ataxia, hydrocephalus imaging, intractable vomiting, or house-bound dizziness warrant urgent neurosurgical liaison even between routine scans.

• Persistent or total hearing loss, tinnitus distress, and oscillopsia after vestibular deafferentation.
• Facial nerve injury → exposure keratitis—ophthalmology partnership.
• CSF leak, meningitis, intracranial haemorrhage, or venous thrombosis after skull-base surgery—unit-specific protocols.
• Radiation-induced cranial neuropathy or cystic tumour expansion—late presentations.
• Hydrocephalus from mass or scarring—may require CSF diversion.

There is no population-wide prevention for sporadic vestibular schwannoma. Clinician-facing mitigation targets early detection of unilateral auditory decline, occupational hearing protection where noise exposure coexists, and genetic cascade screening when NF2 is known—offering predictive MRI timelines to at-risk relatives via genetics services.

Many small tumours remain stable for years; others grow steadily but remain surgically manageable when caught before critical brainstem distortion. Long-term morbidity usually revolves around hearing, balance confidence, and facial nerve function—set expectations honestly: symptom resolution is incomplete for numerous patients despite “successful” oncological control. NF2-related disease carries heavier multi-tumour burden and earlier intervention cycles.

• Front-load medication teaching when dexamethasone bridges are used: mood, glucose, sleep, infection vigilance—patients rarely connect steroids with hyperglycaemia.
• Corneal safety: lubricating drops, eyelid closure at night, and early ophthalmology if blink weakens post-op.
• Communication: offer written summaries for single-sided deafness strategies (CROS aids, FM systems) because fatigue is invisible on observation charts.
• Document orthostatic symptoms after decompressive therapy—autonomic and vestibular compensations lag weeks.

• Neuro baseline each shift: GCS/AVPU, pupils, limb power, cerebellar signs, speech.
• Cranial nerves V–XII if post-CPA surgery or large residual—especially facial movement and palatal elevation.
• Pain / nausea / emesis control trending; anti-emetic choice compatibility with sedation goals.
• Fluid balance & drain outputs per CSF leak pathway.
• Glucose if on steroids; DVT prophylaxis compliance per orthopaedic/neurosurgery protocol.
• Mobility: two-person assist until physiotherapy clears—eye-closed Romberg unsafe solo.

• Thunderclap or rapidly worsening headache with vomiting, somnolence, or new focal neurology.
• Sustained elevated blood pressure with visual obscurations in a known large CPA mass (possible ICP crisis).
• High fever with meningismus after skull-base surgery or CSF leak suspicion.
• Acute airway compromise from lower cranial nerve dysfunction—rare but catastrophic.

Symptom patterns

• Stepwise facial weakness or inability to close eye after previously stable post-op course.
• Recurrent projectile vomiting without ileus explanation.
• Profound worsening imbalance over <24 h in context of known VS.

Objective cues

• New pupillary asymmetry, downward drift in consciousness, or sudden hypertension/bradycardia (Cushing triad late).
• CSF drain suddenly zero output or >expected output—neurosurgery notify.

Escalation

Activate rapid response / neurocritical care per local policy; gather operative note, latest imaging CD, and anticoagulation status at bedside for consultant handover.

Pre-treatment education

• Clarify MRI safety (implants), gadolinium discussions, and realistic hearing outlook.
• Teach orthostatic precautions when vertigo prominent.

Peri-operative / radiosurgery care

• Airway, swallow, and speech checks per neurosurgery protocol; suction readiness if lower cranial nerves at risk.
• Eye care bundles when blink incomplete.
• Radiation: skin site marking integrity, steroid-induced hyperglycaemia surveillance if ordered.

Discharge & evaluation

• Coordinate audiology, vestibular rehab, and psychology referrals for tinnitus distress.
• Evaluate effectiveness via objective falls count, documented hearing aid use, pain scores, and readmission flags—not generic “patient states okay.”

These NCLEX-style clinical judgment practice items focus on the nursing priorities in acoustic neuroma (vestibular schwannoma): recognising unilateral hearing loss/tinnitus and balance cues, supporting safe assessment (fall risk, cranial-nerve checks), spotting red flags (severe headache, vomiting, new facial weakness, signs of hydrocephalus) and evaluating post-operative neuro status (facial-nerve function, CSF leak, dizziness/fall risk). Decisions about watch-and-scan, radiosurgery or microsurgery are MDT-led and noted here as context only.